3.210USD+0.94%Mkt Cap: 643.18M $P/E: —1d ago
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a propriet…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap643.18M $
Enterprise Value660.85M $
Revenue (TTM)216.56M $
Gross Profit112.29M $
Net Income (TTM)-15.63M $
Revenue/Share1.126 USD
Last Price3.210 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees261
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-408.94
EV/Revenue3.05
P/S2.97
P/B9.53
EPS (TTM)-0.05
EPS (Forward)0.00
52W Range
1.15089% of range3.470
52W High3.470 USD
52W Low1.150 USD
Profitability
Gross Margin54.47%
Oper. Margin-0.66%
EBITDA Margin-0.75%
Profit Margin-7.58%
ROE-24.33%
ROA-7.04%
Growth
Revenue Growth24.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF4.84M $
CapEx (TTM)3.73M $
FCF Margin1.04%
FCF Yield0.35%
Net Debt16.93M $
Net Debt/EBITDA-10.48
Balance Sheet
Debt/Equity1.51
Current Ratio1.63
Quick Ratio1.02
Book Value/Sh0.3370 USD
Cash/Share0.4010 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.667 USD
Upside (mean)+45.4%
Target Range4.000 USD – 5.000 USD
$4.000+45.4% to mean$5.000
# Analysts3
Ownership
Shares Out.200.37M
Float182.92M
Insiders3.40%
Institutions73.30%
Short Interest
Short Ratio4.7d
Short % Float6.55%
Short % Out.6.36%
Shares Short12.74M
Short (prev mo.)10.77M
Technical
SMA 502.764 (+16.1%)
SMA 2002.151 (+49.2%)
Beta1.77
S&P 52W Chg20.25%
Avg Vol (30d)2.59M
Avg Vol (10d)2.54M
Technical Indicators
RSI (14)65.1
MACD0.1475
MACD Signal0.1376
MACD Hist.+0.0098
BB Upper3.449 USD
BB Middle2.937 USD
BB Lower2.425 USD
BB Width34.87%
ATR (14)0.1794 USD
Vol Ratio (20d)0.65x